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ARTERIOPORTAL FISTULAS (APF) IN LIVER
TUMORS: PROGNOSIS IN RELATION TO
TREATMENT
ANATOLY M. GRANOV, PAVEL G. TARAZOV and VLADIMIR K.
RYZHKOV
Central Research Institute of Roentgenology and Radiology, Leningrad, USSR
(Receioed 3rd April 1991).
Prognosis of 16 patients with hepatic tumors and angiographically proven arterioportal fistulas was
analysed in relation to treatment. Six patients received only conservative therapy; they all died of
variceal bleeding in the course of two months after angiography. Hepatic resection was performed in
four patients; three of them are still alive 13-52 months later including two free of both the tumor and
portal hypertension. Hepatic artery embolization was carried out in six patients. All of them died in 2-
36 months after the procedure, but only two from gastroesophageal hemorrhage.
It is concluded that prognosis of arterioportal fistulae in liver neoplasms is poor due to hyperkinetic
portal hypertension and following variceal bleeding. Hepatic resection of both the tumor and the fistula
is the treatment of choice. In unresectable cases hepatic artery embolization will decrease the risk of
variceal hemorrhage.
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INTRODUCTION
Shunts between the hepatic artery and the portal vein are present in most malignant
liver neoplasms1’. They are frequently small and therefore not always seen on
arteriograms3’4. Large intrahepatic APF were documented angiographically in 10 to
63 per cent of hepatocellular carcinoma (HCC)5-7. APF are uncommon in hepatic
metastases or benign tumors3’8’9.
There are few reports dealing with the clinical picture and treatment of APF in
liver neoplasms1’11. This report presents our results about prognosis of APF in
hepatic tumors in relation to treatment.
MATERIALS AND METHODS
Hepatic angiography was performed in 130 patients with liver tumors. APF were
documented in 15 (42%) of 36 patients with HCC and in one (5%) of 22 patients
with benign liver neoplasms. There was no APF among 72 patients with hepatic
metastases.
Sixteen patients with APF were distributed in three groups in relation to
treatment. Six patients with hepato-cellular carcinoma including four with underly-
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ing cirrhosis received only conservative therapy (Group A). They were all inoper-
able. Hepatic artery embolization (HAE) was not performed in three cases because
of both the massive tumor and poor patients’ condition. The three remaining
patients were treated before the clinical use of HAE in our hospital. Resection of
both the tumor and the APF was performed in four cases of HCC including two
with concomitant cirrhosis (Group B). Proximal HAE with Spongostan (Ferrosan,
Copenhagen, Denmark) 2 2 2 mm cubes and home-made steel coils12 was
carried out in six patients of Group C (five with HCC including three with cirrhosis,
and one hepatic hemangiomatosis).
RESULTS
Group A
Clinical evidence of malignant liver neoplasmincluding abdominal pain, hepatome-
galy, and palpable mass was present in all patients. Symptoms of severe hyperkine-
tic portal hypertension were present in all 6 cases as well. They included cutaneous
vascular spiders, extensive gastroesophageal varices, and ascitis. Four patients
previously suffered from gastroesophageal or nasal hemorrhage. Three patients
were classified as Okuda’s stage 2 and the remaining three as Okuda’s stage 3 liver
tumor13. Angiography showed advanced neoplasms occupying 30 to 80 per cent of
the liver, and massive APF with early opacification of the main portal trunk (Figure
1).
Figure 1 Celiac angiography of the patient with hepatoma on cirrhosis shows malignant tumor
occupying 80% of the liver, and large APF. Portal vein flow is slowed-up. The patient died 3 days after
angiography from variceal bleeding.APF IN LIVER TUMORS 89
In spite of conservative therapy, portal hypertension and hepatic insufficiency
progressed. All patients died of variceal gastroesophageal bleeding in 3-60
(30.8 +__ 21.8) days after angiography.
Group B
Hepatic resection was performed in 4 patients with tumors occupying 10 to 30 per
cent of the liver. Three of them had Okuda’s stage 1 and the remaining one
Okuda’s stage 2 hepatic tumor. Endoscopy showed gastroesophageal varices of
moderate size in all cases. Ascites was present in three patients. Two patients had
episodes of nasal hemorrhage. Angiography showed absence of significant portal
vein thrombosis and presence of intrahepatic APF of various size. The right main
portal branch in three cases and the main portal trunk in the remaining case were
seen (Figure 2).
Right hepatectomy in two cases and trisegmentectomy in two patients was
carried out. There was no mortality or complications after surgery. All patients
noted improvement of overall condition and disappearance of their complaints.
Control endoscopy showed complete absence of varices. Ascites disappeared in all
three cases as well.
Now two patients are alive and asymptomatic 13 and 29 months after hepatic
resection. Recurrence of the tumor but without arteriportal shunting appeared in
one patient 44 months later. Peripheral HAE was twice performed, and the patient
is well with 50 per cent tumor decreases 52 months after surgery. The remaining
patient died 10 months later from lung metastases.
Figure 2 Celiac angiography of the patient with hepatocellular carcinoma reveals the tumor and large
APF in upper liver segments. The patient is well 29 months after hepatic resection.90 A.M. GRANOV ETAL.
Group C
Proximal embolization of the hepatic artery was performed in 6 patients. Clinical
and radiological investigation showed unresectable tumors (five HCC and one
capillary hemangiomatosis) with extensive gastroesophageal varices in all cases and
ascites in five cases. Four patients experienced gastroesophageal or nasal hemorr-
hage. Angiography confirmed the existence of a malignant or benign tumor
occupying 30 to 60 per cent of the liver, and massive APF with opacification of the
main portal trunk in three cases and the right or left portal vein in three cases. Four
patients were classified as Okuda’s stage 2 and two as Okuda’s stage 3 hepatic
tumor.
The Seldinger technique via the femoral or left axillary artery was used for
catheterization of the hepatic artery. Occlusion of the right (3), right and proper
(2), proper and common (1) hepatic arteries with Spongostan cubes and coils was
performed (Figure 3a,b). We did not use Ivalon or other small particles because of
both the presence of arterioportal shunting and the risk of hepatic failure through
massive ischemic necrosis of the tumor.
A postembolization syndrome lasted 7 to 10 days and included abdominal pain,
nausea, vomiting, fever, and increased level of liver enzymes. There was partial
tumor decrease in 5 patients and no changes in one remaining patient 15-30 days
later.
In this group, three patients died in 5, 6 and 30 months respectively after HAE
from progression of the neoplasm without evidence of bleeding. One patient with
hepatic hemangiomatosis was asymptomatic up to her death from pelvic bone
sarcoma three years later. The two remaining patients died from variceal gastroeso-
phageal hemorrhage 2 and 4 months after HAE. These deaths could be explained
by rearterialization of the liver via collaterals and restoration of APF.
In total, bleeding from varices developed in 2 of 6 patients after HAE.
DISCUSSION
Intrahepatic APF are present in most primary malignant liver tumors16.
Alternatively, APF may be congenital14’15, idiopathic16, or occur as a consequence
of blunt or penetrating, includin iatrogenic, trauma17-2, hepatic cirrhosis8’9,
rupture of hepatic artery aneurysm’21’22.
When the APF is large and has a well-defined image on angiograms, significant
hemodynamic changes in the portal circulation develop, such as diversion of flow
and appearance of portal hypertension with extensive gastroesophageal varices 1’23.
Variceal bleeding occurs in almost all patients with both HCC and APF; conserva-
10 11 tive treatment is not effective Our experience confirmed these data: fatal
hemorrhage developed in the course of two months in all 6 patients receiving only
symptomatic therapy.
In our series, 9 of 16 patients had concomitant hepatic cirrhosis. It was difficult to
determine whether the cirrhosis or the APF had been more responsible for elevated
portal pressure. However, presence of portal hypertension in all patients without
cirrhosis showed that APF had a leading role in the development of extensive
esophageal varices.APF IN LIVER TUMORS 91
Figure 3 (a) Hepatic angiography of the patient with hepatoma on cirrhosis shows malignant tumor and
APF in the right liver lobe. (b) After embolization of the right hepatic artery APF does not fill up. The
patient died 30 months later from tumor progression.92 A.M. GRANOV ET AL.
It was interesting that the extent of APF correlated with tumor volume. All
patients of Group A had arterioportal shunting with early opacification of the main
portal trunk. On the other hand, only the right or left main portal branch was seen
on angiograms in 3 of 4 Group B patients and in 3 of 6 Group C patients. The site of
conjunction between an enlarged nutritive artery and the portal vein as well as the
true size ofAPF itself could be accurately determined in only two patients of Group
B (Figure 2). In the remaining 14 cases multiple small anastomoses within the
neoplasm were seen.
Thus, it is possible to state that APF in both malignant and nonmalignant liver
diseases need special management. Hepatic resection is the treatment of
choice’2’24, this is born out by our results" three of four patients are still alive
13-52 months after surgery.
However, radical resection is often impossible because of an advanced tumor.
Interruption of hepatic arterial flow to the fistula is necessary in such cases.
Nagasue et al. recommended hepatic artery ligation for the triad including HCC,
gastroesophageal varices, and APF. Mays
25 had the same view and affirmed that
APF (excluding iatrogenic) did not disappear spontaneously.
Kim et al.
26 considered that a large APF was always life-threatening from rupture
or progression of portal hypertension with variceal bleeding. The authors described
HAE in three patients with large non-tumor APF and recommended that method
as an alternative to surgical ligation. Other investigators have presented similar
results18,19,23,27.
Morse et al.
1 performed HAE in four patients with both HCC and APF, and
thus normalized hepatic hemodynamics and re-established hepatopetal portal
blood flow. Variceal hemorrhage was stopped in all three bleeders. Three patients
died 2 to 150 days after HAE, the remaining patient was alive 10 months after
embolization without further bleeding. Our results are comparable with this data.
One patient died 30 months after HAE and four patients died in the course of 6
months, but only two of variceal hemorrhage. One remaining patient died of a
tumor unrelated with hepatic hemangiomatosis and APF.
Various embolic materials were used for embolization of APF" steel coils,
11 Gelfoam and Ivalon particles, isobutyl-2-cyanoacrylate ,17,23,27. The authors usually
performed superselective embolization of APF. When large APF is revealed on
angiograms, we consider that only proximal HAE should be used. Usage of small
particles or powders increases the risk of postembolic complications because of
their possible passage into the portal circulation. Besides, proximal HAE despite
its lesser effectiveness (if compared with peripheral HAE) allows treatment of the
tumor and APF simultaneously and to obtain remission in some cases.
Significant systemic hemodynamic changes including reduction of blood pres-
sure, increase in pulse rate and hyperdynamic cardiac failure in infantile hepatic
hemangioendothelioma have been reported-3. However, no serious cardiovascu-
lar changes were detected in patients with malignant and nonmalignant intrahepatic
APF1’1’9’23. Also we did not see any evidence of an APF influence on central
hemodynamics, even in cases of massive arterioportal shunting. Normalization of
both the slightly reduced arterial blood pressure and the moderate tachycardia in
two patients of Group B and three patients of Group C could be explained by
general improvement with decreased intoxication due to the good therapeutic
effect of the treatment.APF IN LIVER TUMORS 93
The investigation of portal pressure before and after surgery and HAE would be
interesting, but we considered that such direct invasive measurements were
contraindicated in our patients, most of whom were in poor condition.
Information in the literature about effectiveness of HAE in malignant APF is
limited. Our groups of patients are small and have considerable differencies in
tumor volume and stage of liver involvement. That is why the results of treatment is
not fully comparable. Further investigations are needed. However, it is possible to
state that prognosis for patients with hepatic tumors complicated by APF is poor
because of development of hyperkinetic portal hypertension and subsequent
variceal gastroesophageal bleeding. The treatment depends on the extent of liver
involvement. Resection of the neoplasm together with the APF is the treatment of
choice. In unresectable cases hepatic artery embolization decreases the risk of
variceal hemorrhage.
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